Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is forecasted to see strong growth in 2026 based on its solid core growth rate, with the company expecting to see 21%-31% growth, excluding the impact of a $55 million CID and a $15 million inventory benefit headwind. This growth potential, combined with the company's current share price weakness, presents an excellent buying opportunity for investors with a long-term horizon. With risks in both directions, including potential competition and slower growth in specialty and utilization, thorough analysis and evaluation of the factors that are material to the company's ESG performance are crucial for establishing an accurate price target.

Bears say

Option Care Health is facing numerous challenges, including weaker-than-expected top-line performance due to unexpected headwinds in certain drug categories and high operating expenses. While the company has identified potential areas for cost savings and expects to see increased revenue in the second half of 2026, it is uncertain if these efforts will be enough to achieve its optimistic financial guidance. Additionally, the company holds a significant amount of debt and has been using a large portion of its cash flow for share buybacks, raising concerns about its financial stability and ability to invest in future growth opportunities.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Aug 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.